| Food Effect Study for PF-06372865 (NCT02217787) | Pfizer | 2014-09-01 |
| Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC) (NCT02305056) | University Hospital, Grenoble | 2014-09-01 |
| Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects (NCT02341638) | Bristol-Myers Squibb | 2014-09-01 |
| Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment (NCT03591471) | Henan University of Traditional Chinese Medicine | 2014-09-01 |
| An Investigation of TAS-119 Monotherapy (NCT02448589) | Taiho Oncology, Inc. | 2014-09-01 |
| A Pharmacokinetic Study of Minocycline in Male and Female Volunteers (NCT02250859) | Vyne Therapeutics Inc. | 2014-09-01 |
| A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects (NCT02279485) | Eisai Inc. | 2014-09-01 |
| Pharmacokinetic Study of MIN-101 in Healthy Subjects (NCT02232529) | Minerva Neurosciences | 2014-09-01 |
| Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury (NCT02237547) | Translational Biosciences | 2014-09-01 |
| Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions (NCT02224651) | Pfizer | 2014-09-01 |
| Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia (NCT02113982) | Stemline Therapeutics, Inc. | 2014-09-01 |
| Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment (NCT02244827) | Wockhardt | 2014-09-01 |
| Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients (NCT01994200) | Jewish General Hospital | 2014-09-01 |
| MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC (NCT02369198) | Asbestos Diseases Research Foundation | 2014-09-01 |
| A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer (NCT02252913) | Hutchison Medipharma Limited | 2014-09-01 |
| A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers (NCT02236026) | Population Council | 2014-09-01 |
| HFS in the Assessement and Management of Severe Asthma Attack Among Fifth Year Medical School Students (NCT02776358) | University of Monastir | 2014-09-01 |
| Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers (NCT02208934) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2014-09-01 |
| Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers (NCT02318758) | United Therapeutics | 2014-09-01 |
| Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age (NCT01975012) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-09-01 |
| Biofeedback for Adolescent Cannabis Use Disorder (NCT02059083) | Denver Health and Hospital Authority | 2014-09-01 |
| A Study of How the Body Breaks Down and Eliminates LY2623091 (NCT02242981) | Eli Lilly and Company | 2014-09-01 |
| Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer (NCT02244632) | Isofol Medical AB | 2014-09-01 |
| Effects of Age, Gender & Race on the Pharmacokinetics (PK)of DS-1971a (NCT02261376) | Daiichi Sankyo | 2014-09-01 |
| CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) (NCT03508635) | Corcept Therapeutics | 2014-09-01 |
| Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury (NCT02248051) | Complexa, Inc. | 2014-09-01 |
| Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT (NCT02400619) | Xavi Vidal Novellas | 2014-09-01 |
| Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis (NCT02756546) | Cairo University | 2014-09-01 |
| Safety and Feasibility Study of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess Cavities (NCT02240498) | University of Rochester | 2014-09-01 |
| Effects of GABA Modulator AZD7325 on Cortical Excitability (NCT02135198) | University College, London | 2014-09-01 |
| Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop (NCT02328040) | Albert Einstein College of Medicine | 2014-09-01 |
| A Safety and Tolerability Study of CTP-730 in Healthy Volunteers (NCT02239081) | Concert Pharmaceuticals | 2014-09-01 |
| A Phase 1 Drug-drug Interaction Study in Healthy Volunteers (NCT02227173) | Bristol-Myers Squibb | 2014-09-01 |
| Safety and Efficacy of BMMNC in Patients With Chronic Renal Failure (NCT01876017) | Chaitanya Hospital, Pune | 2014-09-01 |
| Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis (NCT02314429) | University Ghent | 2014-09-01 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors (NCT02220738) | AbbVie | 2014-09-01 |
| Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta (NCT02479646) | Mylan Inc. | 2014-09-01 |
| The Efficacy of Alcohol After Betadine and Combination of Alcohol and Betadine on Inflammation Vascular Access (NCT02263196) | Mashhad University of Medical Sciences | 2014-09-01 |
| RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients (NCT02257177) | Galecto Biotech AB | 2014-09-01 |
| Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole (NCT02299687) | Seoul National University Hospital | 2014-09-01 |
| Evaluation of a New Imagingtechnologie for Thrombosis (NCT02469376) | University of Zurich | 2014-09-01 |
| Evaluating Anodal tDCS Preceding Aphasia Therapy (NCT02249819) | Northwell Health | 2014-09-01 |
| An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant (NCT02285647) | Tesaro, Inc. | 2014-09-01 |
| The Feasibility and Safety of No-scar Transanal Total Mesorectal Excision for Rectal Cancer (NCT02236884) | Sun Yat-sen University | 2014-09-01 |
| A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS) (NCT02243124) | Eleos, Inc. | 2014-09-01 |
| Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis (NCT02237846) | Translational Biosciences | 2014-09-01 |
| Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment (NCT02269605) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2014-09-01 |
| Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects (NCT02282605) | Destiny Pharma Plc | 2014-09-01 |
| Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients (NCT02206425) | Oncotherapeutics | 2014-09-01 |
| Education Interventions for Self-Management of Pain Post-SCI: A Pilot Study (NCT02262234) | Kessler Foundation | 2014-09-01 |
| Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927 (NCT02230033) | Aragon Pharmaceuticals, Inc. | 2014-09-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects (NCT02342041) | Suven Life Sciences Limited | 2014-09-01 |
| Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting (NCT02473887) | Hamad Medical Corporation | 2014-09-01 |
| A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers (NCT02154425) | UCB BIOSCIENCES, Inc. | 2014-09-01 |
| Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants (NCT02228239) | Janssen Research & Development, LLC | 2014-09-01 |
| Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia (NCT01958177) | Chaitanya Hospital, Pune | 2014-09-01 |
| Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating (NCT01903044) | Pontifícia Universidade Católica do Paraná | 2014-09-01 |
| Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers (NCT02202512) | Boehringer Ingelheim | 2014-09-01 |
| Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) (NCT02228304) | Neurotech Pharmaceuticals | 2014-09-01 |
| A Study of VIS410 to Assess Safety and Pharmacokinetics (NCT02045472) | Visterra, Inc. | 2014-09-01 |
| Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject (NCT02504606) | Huons Co., Ltd. | 2014-09-01 |
| Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide (NCT02231684) | Novo Nordisk A/S | 2014-09-01 |
| Evaluate the Effect of Elimune Capsules (NCT02251678) | Elorac, Inc. | 2014-09-01 |
| Thermal Clinic Treatment in Gulf War Illness (NCT02293291) | American Society Of Thermalism And Climatology Inc | 2014-09-01 |
| Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (NCT02330276) | Veterans Medical Research Foundation | 2014-09-01 |
| Topiramate-Phentermine Combinations for Cocaine Dependence (NCT02239913) | University of Kentucky | 2014-09-01 |
| Drug-Drug Interaction Study in Healthy Adult Volunteers (NCT02275962) | Kowa Research Institute, Inc. | 2014-09-01 |
| A Study of E2022 Tape Formulation (Overlay-integrated E2022 18 mg Tape Formulation) for Different Application Sites and Intervals in Japanese Healthy Elderly Males (NCT02225288) | Eisai Co., Ltd. | 2014-09-01 |
| A mGlu2/3 Agonist in the Treatment of PTSD (NCT02234687) | NYU Langone Health | 2014-09-01 |
| A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults. (NCT01937455) | International AIDS Vaccine Initiative | 2014-09-01 |
| A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma (NCT02095574) | AbbVie | 2014-09-01 |
| A Study of Evacetrapib in Healthy Japanese Participants (NCT02226653) | Eli Lilly and Company | 2014-09-01 |
| A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab (NCT02173392) | Bausch Health Americas, Inc. | 2014-09-01 |
| Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin (NCT03011970) | University Hospital, Bonn | 2014-09-01 |
| Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects (NCT02225626) | Boehringer Ingelheim | 2014-09-01 |
| Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome (NCT02333760) | Genethon | 2014-09-01 |
| Mifepristone for the Prevention of Relapses of Alcohol Drinking (NCT02243709) | Brown University | 2014-09-01 |
| A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a) (NCT02241772) | Xention Ltd | 2014-09-01 |
| Abuse Liability and Human Pharmacology of Mephedrone (NCT02232789) | Parc de Salut Mar | 2014-09-01 |
| the Pharmacokinetic Profiles of Linagliptin With DW1029M (NCT02212782) | Dong Wha Pharmaceutical Co. Ltd. | 2014-09-01 |
| Regeneration of Pulp-Dentin Development in Teeth With Necrotic Pulps and Immature Roots (NCT01976065) | Kenneth Hargreaves | 2014-09-01 |
| Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS (NCT02273635) | Innobioscience SpA | 2014-09-01 |
| Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg. (NCT02583464) | Laboratorio Elea Phoenix S.A. | 2014-09-01 |
| Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500 (NCT02489487) | Viriom | 2014-09-01 |
| A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02204085) | Beth Israel Deaconess Medical Center | 2014-09-01 |
| Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions (NCT02237807) | Pharmaceutical Research Unit, Jordan | 2014-09-01 |
| Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral Vasospasm (NCT02775318) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2014-09-01 |
| Study to Assess the Relative Bioavailability of Orally Administered JNJ-42756493 Tablet Versus JNJ-42756493 Capsule in Healthy Participants (NCT02231489) | Janssen Research & Development, LLC | 2014-09-01 |
| Drug-Drug Interaction Study: ASP2151 and Ritonavir (NCT02223351) | Maruho Europe Limited | 2014-09-01 |
| Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins (NCT02230163) | Centre Hospitalier Universitaire de la Guadeloupe | 2014-09-01 |
| Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers (NCT02259179) | Orexigen Therapeutics, Inc | 2014-09-01 |
| Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus. (NCT01832441) | Chaitanya Hospital, Pune | 2014-09-01 |
| Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers (NCT02256930) | Maruho North America Inc. | 2014-09-01 |
| CKD-828 (80/5mg) Pharmacokinetic Study (NCT02250833) | Chong Kun Dang Pharmaceutical | 2014-09-01 |
| Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection (NCT02109224) | National Cancer Institute (NCI) | 2014-09-01 |
| Bioavailability of LY03004 and Risperdal® Consta® (NCT02091388) | Luye Pharma Group Ltd. | 2014-09-01 |
| Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904 (NCT02243319) | Hanmi Pharmaceutical Company Limited | 2014-09-01 |
| Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS (NCT02492516) | Royan Institute | 2014-09-01 |
| Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients (NCT02143050) | University of Louisville | 2014-09-01 |
| A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT02277392) | Abramson Cancer Center at Penn Medicine | 2014-09-01 |